Till startsida
Sahlgrenska Academy Department of Urology
Sitemap
To content Read more about how we use cookies on gu.se

Karin Welen

Researcher

OverviewPublicationsUNDEFINEDUNDEFINEDUNDEFINED

Karin Welen
Researcher
karin.welen@urology.gu.se
+46 31 786 6754

Room number: 4526B
Postal Address: Su sahlgrenska, 41345 Göteborg
Visiting Address: Medicinaregatan 1F , 41390 Göteborg


Department of Urology at Institute of Clinical Sciences (More Information)
Sahlgrenska Universitetssjukhuset
413 45 Göteborg
0313424145
Visiting Address: Bruna stråket 11b V 2 SU/Sahlgrenska , 413 45 Göteborg

Research areas

Latest publications

Circulating tumor cells mirror bone metastatic phenotype in prostate cancer
Andreas Josefsson, Karin Larsson, Marianne Månsson, Jens Björkman, Eva Rohlova et al.
Oncotarget, Journal article 2018
Journal article

Read the full text
on a web page

Analysis of regulator of G-protein signalling 2 (RGS2) expression and function during prostate cancer progression
Anna Linder, M. Hagberg Thulin, Jan-Erik Damber, Karin Welén
Scientific Reports, Journal article 2018
Journal article

Read the full text
on a web page

Castration is a prerequisite for the inhibitory effect of metronomic chemotherapy on the growth of experimental castration-resistant prostate cancer.
Åsa Jellvert, Daniel Åhs, Josefin Olausson, Ingela Franck Lissbrant, Jan-Erik Damber et al.
Acta oncologica (Stockholm, Sweden), Journal article 2018
Journal article

Read the full text
on a web page

Circulating Tumor Cells as a Marker for Progression-free Survival in Metastatic Castration-naïve Prostate Cancer.
Andreas Josefsson, Anna Linder, Despina Flondell Site, Giacomo Canesin, Anna Stiehm et al.
The Prostate, Journal article 2017
Journal article

Read the full text
on a web page

Tasquinimod inhibits prostate cancer growth in bone through alterations in the bone microenvironment.
Lisa U. Magnusson, Malin Hagberg Thulin, Pascale Plas, Anders Olsson, Jan-Erik Damber et al.
The Prostate, Journal article 2016
Journal article

Read the full text
on a web page

Osteoblasts promote castration-resistant prostate cancer by altering intratumoral steroidogenesis.
Malin Hagberg Thulin, Maria E. Nilsson, Pontus Thulin, Jocelyn Céraline, Claes Ohlsson et al.
Molecular and cellular endocrinology, Journal article 2016
Journal article

Read the full text
on a web page

Osteoblasts stimulate the osteogenic and metastatic progression of castration-resistant prostate cancer in a novel model for in vitro and in vivo studies.
Malin Hagberg Thulin, Karin Jennbacken, Jan-Erik Damber, Karin Welén
Clinical & experimental metastasis, Journal article 2014
Journal article

Read the full text
on a web page

Midkine is associated with neuroendocrine differentiation in castration-resistant prostate cancer.
Anna Nordin, Wanzhong Wang, Karin Welén, Jan-Erik Damber
The Prostate, Journal article 2013
Journal article

Read the full text
on a web page

Castration resistant prostate cancer is associated with increased blood vessel stabilization and elevated levels of VEGF and Ang-2.
Tajana Tesan Tomic, Helene Gustavsson, Wanzhong Wang, Karin Jennbacken, Karin Welén et al.
The Prostate, Journal article 2012
Journal article

Read the full text
on a web page

Inhibition of metastasis in a castration resistant prostate cancer model by the quinoline-3-carboxamide tasquinimod (ABR-215050).
Karin Jennbacken, Karin Welén, Anders Olsson, Bengt Axelsson, Marie Törngren et al.
The Prostate, Journal article 2012
Journal article

Read the full text
on a web page

Showing 1 - 10 of 22

2018

Circulating tumor cells mirror bone metastatic phenotype in prostate cancer
Andreas Josefsson, Karin Larsson, Marianne Månsson, Jens Björkman, Eva Rohlova et al.
Oncotarget, Journal article 2018
Journal article

Read the full text
on a web page

Analysis of regulator of G-protein signalling 2 (RGS2) expression and function during prostate cancer progression
Anna Linder, M. Hagberg Thulin, Jan-Erik Damber, Karin Welén
Scientific Reports, Journal article 2018
Journal article

Read the full text
on a web page

Castration is a prerequisite for the inhibitory effect of metronomic chemotherapy on the growth of experimental castration-resistant prostate cancer.
Åsa Jellvert, Daniel Åhs, Josefin Olausson, Ingela Franck Lissbrant, Jan-Erik Damber et al.
Acta oncologica (Stockholm, Sweden), Journal article 2018
Journal article

Read the full text
on a web page

2017

Circulating Tumor Cells as a Marker for Progression-free Survival in Metastatic Castration-naïve Prostate Cancer.
Andreas Josefsson, Anna Linder, Despina Flondell Site, Giacomo Canesin, Anna Stiehm et al.
The Prostate, Journal article 2017
Journal article

Read the full text
on a web page

2016

Tasquinimod inhibits prostate cancer growth in bone through alterations in the bone microenvironment.
Lisa U. Magnusson, Malin Hagberg Thulin, Pascale Plas, Anders Olsson, Jan-Erik Damber et al.
The Prostate, Journal article 2016
Journal article

Read the full text
on a web page

Osteoblasts promote castration-resistant prostate cancer by altering intratumoral steroidogenesis.
Malin Hagberg Thulin, Maria E. Nilsson, Pontus Thulin, Jocelyn Céraline, Claes Ohlsson et al.
Molecular and cellular endocrinology, Journal article 2016
Journal article

Read the full text
on a web page

2014

Osteoblasts stimulate the osteogenic and metastatic progression of castration-resistant prostate cancer in a novel model for in vitro and in vivo studies.
Malin Hagberg Thulin, Karin Jennbacken, Jan-Erik Damber, Karin Welén
Clinical & experimental metastasis, Journal article 2014
Journal article

Read the full text
on a web page

2013

Midkine is associated with neuroendocrine differentiation in castration-resistant prostate cancer.
Anna Nordin, Wanzhong Wang, Karin Welén, Jan-Erik Damber
The Prostate, Journal article 2013
Journal article

Read the full text
on a web page

2012

Castration resistant prostate cancer is associated with increased blood vessel stabilization and elevated levels of VEGF and Ang-2.
Tajana Tesan Tomic, Helene Gustavsson, Wanzhong Wang, Karin Jennbacken, Karin Welén et al.
The Prostate, Journal article 2012
Journal article

Read the full text
on a web page

Inhibition of metastasis in a castration resistant prostate cancer model by the quinoline-3-carboxamide tasquinimod (ABR-215050).
Karin Jennbacken, Karin Welén, Anders Olsson, Bengt Axelsson, Marie Törngren et al.
The Prostate, Journal article 2012
Journal article

Read the full text
on a web page

Showing 1 - 10 of 22

Page Manager: Katarina Olinder Eriksson|Last update: 1/7/2014
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?